Reviews Cefuroxime


No reviews yet.

Cefuroxime Drug Description
Cefuroxime
for Injection USP and Dextrose Injection USP
To reduce the development of drug-resistant bacteria and maintain the effectiveness
of Cefuroxime for Injection USP and Dextrose Injection USP and other antibacterial
drugs, Cefuroxime for Injection USP and Dextrose Injection USP should be used
only to treat or prevent infections that are proven or strongly suspected to
be caused by bacteria.
DRUG DESCRIPTION
Cefuroxime for Injection USP and Dextrose Injection USP is a sterile, nonpyrogenic,
single use, packaged combination of Cefuroxime Sodium USP (crystalline) and
Dextrose Injection USP (diluent) in the DUPLEX sterile container. The DUPLEX
Container is a flexible dual chamber container.
The drug chamber is filled with sterile crystalline Cefuroxime for Injection
USP, a semisynthetic, broad-spectrum, cephalosporin antibiotic for parenteral
administration. It is the sodium salt of (6R,7R)-7-[2-(2-furyl)glyoxylamido]-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,
72-(Z)-(O-methyloxime), carbamate (ester).
Cefuroxime Sodium USP has the following structural formula:







The empirical formula is C16H15N4NaO8S,
representing a molecular weight of 446.4.
Cefuroxime contains approximately 54.2 mg (2.4 mEq) of sodium per gram of cefuroxime
activity.
The diluent chamber contains Dextrose Injection USP. The concentration of Hydrous
Dextrose USP has been adjusted to render the reconstituted drug product iso-osmotic.
Dextrose Injection USP is sterile, nonpyrogenic, and contains no bacteriostatic
or antimicrobial agents.
Hydrous Dextrose USP has the following structural (molecular) formula:







The molecular weight of Hydrous Dextrose USP is 198.17.
Dextrose hydrous USP has been added to the diluent to adjust osmolality (approximately
1.45 g and 2.05 g to 750 mg and 1.5 g dosages, respectively).
After removing the peelable foil strip, activating the seals, and thoroughly
mixing, the reconstituted drug product is intended for single intravenous use.
When reconstituted, the approximate osmolality of the reconstituted solution
for Cefuroxime for Injection USP and Dextrose Injection USP is 290 mOsmol/kg.

The DUPLEX Container is Latex-free, PVC-free, and Di (2-ethylhexyl) phthalate
(DEHP)-free.
The DUPLEX dual chamber container is made from a specially formulated material.
The product (diluent and drug) contact layer is a mixture of thermoplastic rubber
and a polypropylene ethylene copolymer that contains no plasticizers. The safety
of the container system is supported by USP biological evaluation procedures.
Last reviewed on RxList: 4/10/2008




Cefuroxime Drug Description
Cefuroxime
for Injection USP and Dextrose Injection USP
To reduce the development of drug-resistant bacteria and maintain the effectiveness
of Cefuroxime for Injection USP and Dextrose Injection USP and other antibacterial
drugs, Cefuroxime for Injection USP and Dextrose Injection USP should be used
only to treat or prevent infections that are proven or strongly suspected to
be caused by bacteria.
DRUG DESCRIPTION
Cefuroxime for Injection USP and Dextrose Injection USP is a sterile, nonpyrogenic,
single use, packaged combination of Cefuroxime Sodium USP (crystalline) and
Dextrose Injection USP (diluent) in the DUPLEX sterile container. The DUPLEX
Container is a flexible dual chamber container.
The drug chamber is filled with sterile crystalline Cefuroxime for Injection
USP, a semisynthetic, broad-spectrum, cephalosporin antibiotic for parenteral
administration. It is the sodium salt of (6R,7R)-7-[2-(2-furyl)glyoxylamido]-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,
72-(Z)-(O-methyloxime), carbamate (ester).
Cefuroxime Sodium USP has the following structural formula:







The empirical formula is C16H15N4NaO8S,
representing a molecular weight of 446.4.
Cefuroxime contains approximately 54.2 mg (2.4 mEq) of sodium per gram of cefuroxime
activity.
The diluent chamber contains Dextrose Injection USP. The concentration of Hydrous
Dextrose USP has been adjusted to render the reconstituted drug product iso-osmotic.
Dextrose Injection USP is sterile, nonpyrogenic, and contains no bacteriostatic
or antimicrobial agents.
Hydrous Dextrose USP has the following structural (molecular) formula:







The molecular weight of Hydrous Dextrose USP is 198.17.
Dextrose hydrous USP has been added to the diluent to adjust osmolality (approximately
1.45 g and 2.05 g to 750 mg and 1.5 g dosages, respectively).
After removing the peelable foil strip, activating the seals, and thoroughly
mixing, the reconstituted drug product is intended for single intravenous use.
When reconstituted, the approximate osmolality of the reconstituted solution
for Cefuroxime for Injection USP and Dextrose Injection USP is 290 mOsmol/kg.

The DUPLEX Container is Latex-free, PVC-free, and Di (2-ethylhexyl) phthalate
(DEHP)-free.
The DUPLEX dual chamber container is made from a specially formulated material.
The product (diluent and drug) contact layer is a mixture of thermoplastic rubber
and a polypropylene ethylene copolymer that contains no plasticizers. The safety
of the container system is supported by USP biological evaluation procedures.
Last reviewed on RxList: 4/10/2008




Cefuroxime Drug Description
Cefuroxime
for Injection USP and Dextrose Injection USP
To reduce the development of drug-resistant bacteria and maintain the effectiveness
of Cefuroxime for Injection USP and Dextrose Injection USP and other antibacterial
drugs, Cefuroxime for Injection USP and Dextrose Injection USP should be used
only to treat or prevent infections that are proven or strongly suspected to
be caused by bacteria.
DRUG DESCRIPTION
Cefuroxime for Injection USP and Dextrose Injection USP is a sterile, nonpyrogenic,
single use, packaged combination of Cefuroxime Sodium USP (crystalline) and
Dextrose Injection USP (diluent) in the DUPLEX sterile container. The DUPLEX
Container is a flexible dual chamber container.
The drug chamber is filled with sterile crystalline Cefuroxime for Injection
USP, a semisynthetic, broad-spectrum, cephalosporin antibiotic for parenteral
administration. It is the sodium salt of (6R,7R)-7-[2-(2-furyl)glyoxylamido]-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,
72-(Z)-(O-methyloxime), carbamate (ester).
Cefuroxime Sodium USP has the following structural formula:







The empirical formula is C16H15N4NaO8S,
representing a molecular weight of 446.4.
Cefuroxime contains approximately 54.2 mg (2.4 mEq) of sodium per gram of cefuroxime
activity.
The diluent chamber contains Dextrose Injection USP. The concentration of Hydrous
Dextrose USP has been adjusted to render the reconstituted drug product iso-osmotic.
Dextrose Injection USP is sterile, nonpyrogenic, and contains no bacteriostatic
or antimicrobial agents.
Hydrous Dextrose USP has the following structural (molecular) formula:







The molecular weight of Hydrous Dextrose USP is 198.17.
Dextrose hydrous USP has been added to the diluent to adjust osmolality (approximately
1.45 g and 2.05 g to 750 mg and 1.5 g dosages, respectively).
After removing the peelable foil strip, activating the seals, and thoroughly
mixing, the reconstituted drug product is intended for single intravenous use.
When reconstituted, the approximate osmolality of the reconstituted solution
for Cefuroxime for Injection USP and Dextrose Injection USP is 290 mOsmol/kg.

The DUPLEX Container is Latex-free, PVC-free, and Di (2-ethylhexyl) phthalate
(DEHP)-free.
The DUPLEX dual chamber container is made from a specially formulated material.
The product (diluent and drug) contact layer is a mixture of thermoplastic rubber
and a polypropylene ethylene copolymer that contains no plasticizers. The safety
of the container system is supported by USP biological evaluation procedures.
Last reviewed on RxList: 4/10/2008




Cefuroxime Drug Description
Cefuroxime
for Injection USP and Dextrose Injection USP
To reduce the development of drug-resistant bacteria and maintain the effectiveness
of Cefuroxime for Injection USP and Dextrose Injection USP and other antibacterial
drugs, Cefuroxime for Injection USP and Dextrose Injection USP should be used
only to treat or prevent infections that are proven or strongly suspected to
be caused by bacteria.
DRUG DESCRIPTION
Cefuroxime for Injection USP and Dextrose Injection USP is a sterile, nonpyrogenic,
single use, packaged combination of Cefuroxime Sodium USP (crystalline) and
Dextrose Injection USP (diluent) in the DUPLEX sterile container. The DUPLEX
Container is a flexible dual chamber container.
The drug chamber is filled with sterile crystalline Cefuroxime for Injection
USP, a semisynthetic, broad-spectrum, cephalosporin antibiotic for parenteral
administration. It is the sodium salt of (6R,7R)-7-[2-(2-furyl)glyoxylamido]-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,
72-(Z)-(O-methyloxime), carbamate (ester).
Cefuroxime Sodium USP has the following structural formula:







The empirical formula is C16H15N4NaO8S,
representing a molecular weight of 446.4.
Cefuroxime contains approximately 54.2 mg (2.4 mEq) of sodium per gram of cefuroxime
activity.
The diluent chamber contains Dextrose Injection USP. The concentration of Hydrous
Dextrose USP has been adjusted to render the reconstituted drug product iso-osmotic.
Dextrose Injection USP is sterile, nonpyrogenic, and contains no bacteriostatic
or antimicrobial agents.
Hydrous Dextrose USP has the following structural (molecular) formula:







The molecular weight of Hydrous Dextrose USP is 198.17.
Dextrose hydrous USP has been added to the diluent to adjust osmolality (approximately
1.45 g and 2.05 g to 750 mg and 1.5 g dosages, respectively).
After removing the peelable foil strip, activating the seals, and thoroughly
mixing, the reconstituted drug product is intended for single intravenous use.
When reconstituted, the approximate osmolality of the reconstituted solution
for Cefuroxime for Injection USP and Dextrose Injection USP is 290 mOsmol/kg.

The DUPLEX Container is Latex-free, PVC-free, and Di (2-ethylhexyl) phthalate
(DEHP)-free.
The DUPLEX dual chamber container is made from a specially formulated material.
The product (diluent and drug) contact layer is a mixture of thermoplastic rubber
and a polypropylene ethylene copolymer that contains no plasticizers. The safety
of the container system is supported by USP biological evaluation procedures.
Last reviewed on RxList: 4/10/2008




Cefuroxime Drug Description
Cefuroxime
for Injection USP and Dextrose Injection USP
To reduce the development of drug-resistant bacteria and maintain the effectiveness
of Cefuroxime for Injection USP and Dextrose Injection USP and other antibacterial
drugs, Cefuroxime for Injection USP and Dextrose Injection USP should be used
only to treat or prevent infections that are proven or strongly suspected to
be caused by bacteria.
DRUG DESCRIPTION
Cefuroxime for Injection USP and Dextrose Injection USP is a sterile, nonpyrogenic,
single use, packaged combination of Cefuroxime Sodium USP (crystalline) and
Dextrose Injection USP (diluent) in the DUPLEX sterile container. The DUPLEX
Container is a flexible dual chamber container.
The drug chamber is filled with sterile crystalline Cefuroxime for Injection
USP, a semisynthetic, broad-spectrum, cephalosporin antibiotic for parenteral
administration. It is the sodium salt of (6R,7R)-7-[2-(2-furyl)glyoxylamido]-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,
72-(Z)-(O-methyloxime), carbamate (ester).
Cefuroxime Sodium USP has the following structural formula:







The empirical formula is C16H15N4NaO8S,
representing a molecular weight of 446.4.
Cefuroxime contains approximately 54.2 mg (2.4 mEq) of sodium per gram of cefuroxime
activity.
The diluent chamber contains Dextrose Injection USP. The concentration of Hydrous
Dextrose USP has been adjusted to render the reconstituted drug product iso-osmotic.
Dextrose Injection USP is sterile, nonpyrogenic, and contains no bacteriostatic
or antimicrobial agents.
Hydrous Dextrose USP has the following structural (molecular) formula:







The molecular weight of Hydrous Dextrose USP is 198.17.
Dextrose hydrous USP has been added to the diluent to adjust osmolality (approximately
1.45 g and 2.05 g to 750 mg and 1.5 g dosages, respectively).
After removing the peelable foil strip, activating the seals, and thoroughly
mixing, the reconstituted drug product is intended for single intravenous use.
When reconstituted, the approximate osmolality of the reconstituted solution
for Cefuroxime for Injection USP and Dextrose Injection USP is 290 mOsmol/kg.

The DUPLEX Container is Latex-free, PVC-free, and Di (2-ethylhexyl) phthalate
(DEHP)-free.
The DUPLEX dual chamber container is made from a specially formulated material.
The product (diluent and drug) contact layer is a mixture of thermoplastic rubber
and a polypropylene ethylene copolymer that contains no plasticizers. The safety
of the container system is supported by USP biological evaluation procedures.
Last reviewed on RxList: 4/10/2008





Other reviews about Cefuroxime on wordpress

Buy Cefuroxime Online Order Cheap Cefuroxime Generic Purchase Discount Without Prescription
  by worlddnews
FOLLOW THIS LINK FOR ENTER TO TRUSTED & REPUTABLE ONLINE DRUGSTORE WHERE YOU CAN GET ALL QUALIFIED INFORMATION ABOUT Cefuroxime ONLINE     Better known as ringing in such as rosemary […]


Nasal Steroids DO Help Resolve Sinusitis More Quickly Than Antibiotics Alone
  by fauquierent
Not sure why more doctors don't prescribe nasal steroids (ie, flonase, nasacort, rhinocort, nasonex, etc) in addition to antibiotics to treat sinusitis, especially those in which it […]


Health
  by Kendall
Six weeks ago I got a cough that since then has stayed with me since. The cough developed from a cold which lasted only a few days.The cold […]


Peri-Operative Medications
  by rockridge
What do you use for peri-operative medications now that the recent ESCRS trial has demonstrated the beneficial effects of intracameral cefuroxime? Click here to view the ESCRS Cefuroxime […]


ESCRS Study - Cefuroxime
  by rockridge
Volume 32, Issue 3, Pages 407-410 (March 2006) ツ   (Abstract from the Journal of Cataract and Refractive Surgery) ツ ツ ツ ツ Link to full article: ESCRS Cefuroxime StudyツResultsツツ ツツ ESCRS study of prophylaxis of postoperative endophthalmitis […]


24 July, 2009
  by emkeane
1. In little girls who are sexually assaulted, if the hymenal ring has been exposed to estrogen, it may show only minimal trauma and crucial evidence for penetration […]


When is a penicillin-allergic patient not penicillin allergic?
  by microbioloblog
The penicillin family of antibiotics and their chemically related cousins, the cephalosporins,ツremain the best treatment options for many serious infections including meniningitis and endocarditis (infection of a heart […]


DJ Aurobindo Pharma Gets Canada Regulatory OK For Generic Antibiotic
  by commodityvn
DJ Aurobindo Pharma Gets Canada Regulatory OK For Generic Antibiotic Wed Mar 03 03:47:21 2010 EST BANGALORE (Dow Jones)--Aurobindo Pharma Ltd. (524804.BY) Wednesday said it has received regulatory […]


Aurobindo gets Canadian nod for antibiotic
  by ivgpartners
Hyderabad-based Aurobindo Pharma has today announced that the company has received an approval from Canada for its antibiotic drug. The drug is called Cefuroxime Axetil Tablets, and is […]


Activity of Ceftaroline against Recent Emerging Serotypes of Streptococcus pneumoniae in the United States
  by JOC
Antimicrob. Agents Chemother. June 2010 V.54 N.6ツ p.2716-2719 Michael R. Jacobs,1* Caryn E. Good,1 Anne R. Windau,1 Saralee Bajaksouzian,1 Donald Biek,2 Ian A. Critchley,2 Helio S. Sader,3 and Ronald […]



Other reviews about Cefuroxime on web:

Cefuroxime is a second-generation cephalosporin antibiotic that has been widely available in the USA as Ceftin since 1977. GlaxoSmithKline sells the antibiotic in the United ... Cefuroxime - Wikipedia, the free encyclopedia


Learn about the prescription medication Ceftin (Cefuroxime Axetil), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Ceftin (Cefuroxime Axetil) Drug Information: Uses, Side Effects ...


Learn about the prescription medication Cefuroxime (Cefuroxime Injection), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Cefuroxime (Cefuroxime Injection) Drug Information: Uses, Side ...


Cefuroxime Brand names: Altiテδ「テつテつ「CeftinテδづつョKefuroxテδづつョZinacefテδづつョ Chemical formula: Drug Forms: Cefuroxime oral suspension (below) Cefuroxime Cefuroxime: Definition from Answers.com


Physician reviewed cefuroxime patient information - includes cefuroxime description, dosage and directions. cefuroxime medical facts from Drugs.com


Drug information on prescription and over the counter medications includes drug interactions, uses, side effects, and drug dosing. cefuroxime - Medications: Prescription Drugs and Over the Counter ...


All about Cefuroxime Tablets. View complete and up to date Cefuroxime information - part of the Drugs.com trusted medication database. Cefuroxime Tablets Facts and Comparisons at Drugs.com


ceテδづつキfurテδづつキoテδづつキxime definition Pronunciation: /si-テδ凝つfy uテδ古つ r-テδ嘉つ-テδ凝つ頚テδテつ杜/ Function: n: a semisynthetic cephalosporin antibiotic that is administered parenterally in the form of its sodium ... Cefuroxime | Define Cefuroxime at Dictionary.com


Consumer information about the medication CEFUROXIME - ORAL (Ceftin), includes side effects, drug interactions, recommended dosages, and storage information. Read more about the ... CEFUROXIME - ORAL (Ceftin) side effects, medical uses, and drug ...


Click on the image to Buy Cefuroxime Online ! Cefuroxime. Generic Name: Cefuroxime Brand Name: Ceftin. Drug Class And Mechanism: Cefuroxime is a semisynthetic cephalosporin ... Cefuroxime Review





Featured Reviews

Reviews Ofloxacin Ophthalmic

Ocuflox Drug Description OCUFLOX (ofloxacin) Ophthalmic Solution DRUG DESCRIPTION What are the possible side effects of ofloxacin ophthalmic (Ocuflox)? Serious side effects are not expected to occur during treatment with this medication. If...
Read More  |  Review This
Reviews Cysview

Cysview Drug Description Cysview (hexaminolevulinate hydrochloride), for Intravesical Solution For bladder instillation only DRUG DESCRIPTION Cysview contains hexaminolevulinate hydrochloride, an optical imaging drug that in solution...
Read More  |  Review This
Reviews Selenium

Selsun Drug Description DRUG DESCRIPTION What are the possible side effects of selenium sulfide topical? Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling...
Read More  |  Review This
Reviews Argatroban Injection

Argatroban Drug Description ARGATROBAN Injection DRUG DESCRIPTION Argatroban is a synthetic direct thrombin inhibitor derived from L-arginine. The chemical name for Argatroban is 1-[5-[(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-...
Read More  |  Review This
Reviews Aralen

Aralen Drug Description ARALEN® (chloroquine phosphate, USP) For Malaria and Extraintestinal Amebiasis DRUG DESCRIPTION What are the possible side effects of chloroquine (Aralen Phosphate)? Stop taking chloroquine and seek...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....